Breakout Sessions—Unlocking Therapeutic Potential: Neuroscience-Informed Discussions on Pharmacological and Non-Pharmacological Approaches to Optimizing Treatment

  • Join a breakout session discussion led by Dr. Olu Ajilore on pharmacologic approaches to optimizing CBT (e.g., ketamine, endocannabinoids, psychedelics) or by Dr. Robin Aupperle on non-pharmacologic approaches (e.g., neuroscience-informed treatment selection, TMS, neurofeedback)
  • Learn about the state-of-the-science of these approaches
  • Barriers to widespread implementation of these approaches

Olu Ajilore, M.D., Ph.D.

University of Illinois-Chicago

Dr. Ajilore is the Center for Depression and Resilience Professor in the Department of Psychiatry at the University of Illinois-Chicago. He graduated magna cum laude from Harvard University with a degree in biology. Dr. Ajilore did his MD/PhD degree at Stanford University where he studied the negative effects of stress hormones on the brain. His lab currently uses computational neuroimaging techniques and digital biomarkers to better track and treat neuropsychiatric disorders. Dr. Ajilore is also serves as the Associate Head for Faculty Development, the director the Mood and Anxiety Disorders Program and as a member of the National Advisory Mental Health Council for NIMH.

Robin Aupperle, Ph.D.

Laureate Institute for Brain Research

Dr. Aupperle was born and raised in rural Oklahoma and obtained her bachelor’s degree in psychology from Oklahoma State University. She received her master’s and doctoral education in clinical health psychology at the University of Kansas, where her research and clinical education focused on neuropsychology, neuroimaging, and anxiety disorders. She then completed clinical internship and postdoctoral fellowship at the VA San Diego Healthcare System and University of California – San Diego, conducting research related to neural substrates of anxiety disorders and PTSD, with a particular emphasis on decision-making processes and treatment. She served as Assistant Professor within the University of Missouri - Kansas City (UMKC) Department of Psychology from 2011-2014. Dr. Aupperle joined the Laureate Institute for Brain Research (LIBR) and The University of Tulsa in 2014, where she is currently Associate Professor. She leads the Neurocognitive Aspects of Anxiety, Trauma, and Treatment (NeuroCATT) Laboratory, whose mission is to conduct translational neuroscience research that has the potential to inform our understanding and optimization of psychotherapy interventions for individuals experiencing anxiety, depression, or trauma-related symptoms. She also serves as Director of Clinical Psychology training at LIBR, which includes leading a clinical internship site at LIBR and Laureate Psychiatric Clinic and Hospital (LPCH).

Key:

Complete
Failed
Available
Locked
Breakout Sessions – Unlocking Therapeutic Potential
06/07/2024 at 11:00 AM (EDT)  |  60 minutes
06/07/2024 at 11:00 AM (EDT)  |  60 minutes
Session Evaluation
7 Questions